LabCorp in talks to buy PPD for $8Bn

By Dani Bancroft contact

- Last updated on GMT

LabCorp in talks to buy the CRO PPD for $8Bn

Related tags: Laboratory, United states, North carolina

Unconfirmed reports suggest Laboratory Corporation of America Holdings (LabCorp) is in talks to acquire contract research organization Pharmaceutical Product Development LLC (PPD).

According to a Reuters report​, a second party is taking part in the auction of PPD with LabCorp, but has not yet been identified​. 

If LabCorp was to acquire PPD, the transaction's value would exceed the $5.7bn for which it purchased Covance​ in 2015.

PPD offers contract research services from inhalation products to biologics​, for a wide range of indications, with headquarters in Wilmington, North Carolina. 

The firm has more than 18,500 employees worldwide and is owned by Carlyle Group LP and Hellman & Friedman LLC, which made the company private in 2011 for $3.9bn.

LabCorp is a North Carolina, US-based clinical lab network with a $14.3bn (€13.3bn) market cap. Last month, it acquired​ Mount Sinai’s clinical outreach laboratories, adding seven patient service centers to its network.

Related news

Show more

Related products

show more

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars